The inflammation, pain, lung injury, plasma osmolarity changes and psychological stress associated with COVID-19 are behind the activation of the stress-adapting endocrine axis with a consequent increase in circulating AVP/copeptin [6,7]. This evidence concerns the gene AVP and COVID-19.